Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.63 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.58 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.58 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.58 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.58 |
| ▸ | LDHA | P00338 | 1/20 | 0.58 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.58 |
| ▸ | FBP1 | P09467 | 1/20 | 0.58 |
| ▸ | SRC | P12931 | 1/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.58 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.58 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.58 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.58 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.58 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30211841 | 0.97 | P2RY2 (0.59) | EHMT1P2RY2DNPH1PRKAB2TRPM2 | |
| SCHEMBL29126399 | 0.97 | P2RY2 (0.59) | EHMT1P2RY2DNPH1PRKAB2TRPM2 | |
| Hydrochloric Acid SCHEMBL30211837 | 0.96 | P2RY2 (0.58) | EHMT1P2RY2DNPH1PRKAB2TRPM2 | |
| Hydrochloric Acid SCHEMBL29126408 | 0.96 | P2RY2 (0.58) | EHMT1P2RY2DNPH1PRKAB2TRPM2 | |
| SCHEMBL4071842 | 0.91 | SRM (0.59) | P2RY2DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL8440946 | 0.91 | P2RY2 (0.60) | P2RY2SRCP2RY1SMN1; SMN2 | |
| SCHEMBL8435885 | 0.87 | P2RY2 (0.62) | P2RY2SRCP2RY1SMN1; SMN2 | |
| SCHEMBL5418087 | 0.86 | SRM (0.57) | P2RY2DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL9008963 | 0.85 | P2RY2 (0.57) | EHMT1P2RY2DNPH1PRKAB2TRPM2 | |
| SCHEMBL9008934 | 0.85 | P2RY2 (0.57) | EHMT1P2RY2DNPH1PRKAB2TRPM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730128-A1 | ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE | Exelixis, Inc. (US) | 2006-12-13 | — | — | EP | claimed |
| WO-2005097765-A1 | ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE | EXELIXIS, INC. (US) | 2005-10-20 | — | — | WO | claimed |
| CN-110914441-B | Improved process for producing isobutene from 3-methylcrotonic acid | 环球生物能源公司 | 2024-06-28 | — | — | CN | disclosed |
| US-12016864-B2 | LOX enzyme inhibiting methods and compositions | ANOVIA BIOSCIENCES, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| CN-118147094-A | Protein capable of catalyzing monoamidation of symmetrical diamine and derived from fungi and application | 上海交通大学 | 2024-06-07 | — | — | CN | disclosed |
| EP-3622080-B1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2024-03-27 | — | — | EP | disclosed |
| WO-2024058717-A1 | ENGINEERING OF RHIZOMUCOR MIEHEI LIPASE TOWARDS AMIDE BOND FORMATION FOR THE SYNTHESIS OF MEDIUM TO LONG CHAIN N-ACYL GLYCINES IN AQUEOUS MEDIA | WILMAR INTERNATIONAL LIMITED (SG) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023250524-A1 | SYSTEMS AND METHODS FOR CELL-FREE ITERATIVE SITE SATURATION MUTAGENESIS AND ITS APPLICATION FOR THE DIRECTED EVOLUTION OF ENZYMES CATALYZING UNNATURAL REACTIONS | NORTHWESTERN UNIVERSITY (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20230390299-A1 | LOX ENZYME INHIBITING METHODS AND COMPOSITIONS | ANOVIA BIOSCIENCES INC (US) | 2023-12-07 | — | — | US | disclosed |
| US-20230310445-A1 | LOX ENZYME INHIBITING METHODS AND COMPOSITIONS | ANOVIA BIOSCIENCES, INC. | 2023-10-05 | — | — | US | disclosed |
| US-20230181621-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2023-06-15 | — | — | US | disclosed |
| WO-2004093650-A2 | METHOD FOR MONITORING BLOOD FLOW AND METABOLIC UPTAKE IN TISSUE WITH RADIOLABELED ALKANOIC ACID | THE GENERAL HOSPITAL CORPORATION (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040014808-A1 | Novel derivatives of carnosic acid | ROSAZZA JOHN P N (US) | 2004-01-22 | — | — | US | disclosed |
| US-20030224376-A1 | Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models | MILLENIUM PHARMACEUTICALS, INC. | 2003-12-04 | — | — | US | disclosed |
| WO-2003087316-A2 | NOVEL DERIVATIVES OF CARNOSIC ACID | KEMIN INDUSTRIES, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-2003076565-A2 | METHODS OF USING 46828, A HUMAN ACYL-COA SYNTHETASE | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2003-09-18 | — | — | WO | disclosed |
| US-20030118507-A1 | Methods of using 46828, a human acyl-CoA synthetase | MILLENNIUM PHARMACEUTICALS, INC. | 2003-06-26 | — | — | US | disclosed |
| US-20030077767-A1 | Genes and proteins for the biosynthesis of anthramycin | THALLION PHARMACEUTICALS INC. (CA) | 2003-04-24 | — | — | US | disclosed |
| WO-2002101051-A2 | GENES AND PROTEINS FOR THE BIOSYNTHESIS OF ANTHRAMYCIN | ECOPIA BIOSCIENCES INC. (CA) | 2002-12-19 | — | — | WO | disclosed |
| WO-2001090322-A2 | 32244, A NOVEL HUMAN AMP-BINDING ENZYME AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310445-A1 | LOX ENZYME INHIBITING METHODS AND COMPOSITIONS | LOX, LOXL1, LOXL2 | EHMT1 1087/4885P2RY2 2028/4885DNPH1 720/4885 |
| US-20040014808-A1 | Novel derivatives of carnosic acid | APEX1, NAA50, DNTT | EHMT1 688/4885P2RY2 4122/4885DNPH1 145/4885 |
| US-20030077767-A1 | Genes and proteins for the biosynthesis of anthramycin | ANTXR2, GABRG1, GABRD | EHMT1 4288/4885P2RY2 4331/4885DNPH1 2335/4885 |
| US-20230390299-A1 | LOX ENZYME INHIBITING METHODS AND COMPOSITIONS | LOX, LOXL1, LOXL2 | EHMT1 1459/4885P2RY2 2047/4885DNPH1 813/4885 |
| US-20230181621-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | ASNS, GLS, GLS2 | EHMT1 3956/4885P2RY2 4005/4885DNPH1 162/4885 |
| US-12016864-B2 | LOX enzyme inhibiting methods and compositions | LOX, LOXL1, LOXL2 | EHMT1 1412/4885P2RY2 1913/4885DNPH1 679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.